| Literature DB >> 30269913 |
Pablo Díez-Villanueva1, Albert Arizá-Solé2, María Teresa Vidán3, Clara Bonanad4, Francesc Formiga5, Juan Sanchis6, F Javier Martín-Sánchez7, Vicente Ruiz Ros8, Marcelo Sanmartín Fernández9, Héctor Bueno10, Manuel Martínez-Sellés11.
Abstract
Frailty is an age-associated clinical syndrome characterized by a decrease in physiological reserve in situations of stress, constituting a state of vulnerability that involves a higher risk of adverse events. Its prevalence in Spain is high, especially in elderly individuals with comorbidity and chronic diseases. In cardiovascular disease, frailty is associated worse clinical outcomes and higher morbidity and mortality in all scenarios, in both acute and chronic settings, and could consequently influence diagnosis and treatment. However, frailty is often not addressed or included when planning the management of elderly patients with heart disease. In this article, we review the available scientific evidence and highlight the most appropriate scales for the measurement and assessment of frailty, some of which are more useful and have better predictive capacity than others, depending on the clinical context. We also underline the importance of properly identifying and assessing frailty in order to include it in the treatment and care plan that best suits each patient.Entities:
Keywords: Cardiopatía; Elderly; Fragilidad; Frailty; Heart disease; Paciente anciano
Mesh:
Year: 2018 PMID: 30269913 DOI: 10.1016/j.rec.2018.06.035
Source DB: PubMed Journal: Rev Esp Cardiol (Engl Ed) ISSN: 1885-5857